Aberdeen Group plc Purchases 294,792 Shares of Alphatec Holdings, Inc. $ATEC
Aberdeen Group plc significantly increased its stake in Alphatec Holdings, Inc. (NASDAQ:ATEC) by 29.7% in Q4, acquiring an additional 294,792 shares, bringing their total to 1,286,195 shares valued at $27.06 million. Despite substantial insider selling amounting to $9.18 million from executives including the General Counsel and COO, Alphatec reported an earnings beat with Q4 EPS of $0.06 against an expected $0.04 and revenue up 20.4% year-over-year. Analysts currently hold a "Moderate Buy" consensus rating with an average price target of $22.82 for the medical technology company.
ATEC PE Ratio & Valuation, Is ATEC Overvalued
Alphatec Holdings Inc (ATEC) is currently considered undervalued, with a forward P/S ratio of 1.58 against a five-year average of -10.90. Its fair price is estimated to be between $17.07 and $31.30, compared to its current price of $11.21, suggesting it is undervalued by 34.29%. The company's P/S ratio of 1.58 is significantly below the competitor average of 4.11, and its robust revenue growth of 20.44% supports this valuation.
Alphatec Holdings EVP Craig Hunsaker Sells Shares - 2026 Transaction Details - News and Statistics
Craig E. Hunsaker, EVP at Alphatec Holdings, sold 116,367 company shares worth approximately $1.44 million in open-market transactions. This sale reduced his direct holdings to 1,725,609 shares, valued at about $22.21 million. A portion of the sale was conducted under a pre-established trading plan to meet tax obligations.
Alphatec CFO Sells 79,789 Shares: Transaction Details & Company Context - News and Statistics
John Todd Koning, the CFO of Alphatec Holdings, sold 79,789 shares of the company's stock for approximately $986,000. Following the sale, Koning retains direct ownership of 600,721 shares valued at about $7.38 million. The transaction is characterized as a routine liquidity event for tax and compensation purposes rather than a reflection of the company's performance.
Alphatec Executive Sells 116,367 Shares Amid Market Fluctuations
Alphatec's EVP, Craig Hunsaker, sold 116,367 shares worth $1.44 million, a significant transaction partly due to tax obligations related to vested restricted stock units. Despite this sale, which reduced his holdings by 6.32%, his remaining $22.21 million stake reflects continued confidence in the company. Alphatec reported 2025 revenues of $764.2 million but a net loss of $143.4 million, with analysts projecting revenue growth for 2026.
US2081GAD4 Bond Analysis — Key Metrics
This article provides a detailed analysis of the US2081GAD4 bond issued by Alphatec Holdings, Inc. Key metrics such as the fixed coupon rate of 0.75%, issue date of March 17, 2026, and maturity date of March 15, 2030, are highlighted. The bond has an outstanding amount of $405 million USD and a face value of $1,000 USD.
US2081GAD4 Bond Price and Chart — FWB:US2081GAD4
This article provides an overview of the Alphatec Holdings, Inc. 0.75% 15-MAR-2030 bond (US2081GAD4) traded on the Frankfurt Stock Exchange. It details key bond terms such as outstanding amount, face value, coupon rate, and maturity date, along with company information for Alphatec Holdings. The page also offers sections for chart analysis, news, and calls to unlock advanced bond data.
ATEC SEC Filings - Alphatec Hldgs Inc 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Alphatec Holdings, Inc. (ATEC) SEC filings, including 10-K, 10-Q, 8-K forms, and insider trading activities. It highlights the use of AI-powered summaries to help investors quickly understand key information from these regulatory documents. Recent filings detail insider stock sales under 10b5-1 plans and proposed sales from restricted stock vesting.
Assenagon Asset Management S.A. Raises Position in Alphatec Holdings, Inc. $ATEC
Assenagon Asset Management S.A. significantly increased its stake in Alphatec Holdings, Inc. (NASDAQ:ATEC) by 30.4%, bringing its total ownership to 978,343 shares valued at $20.58 million. This comes as analysts maintain a "Moderate Buy" rating with a consensus target price of $22.82, and Alphatec recently reported strong quarterly results, beating EPS and revenue expectations. Despite insider selling activity, institutional investors now own 66.35% of the medical technology company.
Alphatec CFO Sells Nearly 80,000 Shares in Direct Transaction
Alphatec's CFO, John Todd Koning, sold nearly 80,000 shares worth approximately $986,000. This transaction, representing 11.7% of his direct holdings, is attributed to tax obligations and liquidity needs rather than concerns about the company's performance. Alphatec reported 25% revenue growth in 2025 and forecasts continued double-digit growth for 2026, with management emphasizing strategic execution and cash flow generation.
Alphatec Holdings Insiders Sell US$13m Of Stock, Possibly Signalling Caution
Insiders at Alphatec Holdings (NASDAQ:ATEC) have sold US$13 million worth of stock over the past year, with a significant portion occurring in the last quarter amounting to US$4.2 million. While insiders still collectively own a substantial 10% of the company, the absence of any insider buying and the continuous selling activity could signal caution to shareholders. The largest single transaction was for US$3.9 million at a price higher than the current share price, but overall, the trend suggests insiders are not viewing the stock as a bargain.
What Alphatec Holdings (ATEC)'s PTP Market Limits and Robotics Gaps Mean For Shareholders
Alphatec Holdings (ATEC) recently reported 4Q 2025 results, raising concerns among investors about its narrow lumbar fusion focus and lagging capabilities in surgical robotics. The company's Prone TransPsoas (PTP) approach appears to serve only a subset of the spine surgery market, potentially limiting its long-term growth. Despite these structural challenges, Alphatec reaffirmed its 2026 revenue guidance, suggesting management confidence in current demand and pipeline initiatives, though this invites scrutiny regarding the reliance on PTP versus newer solutions.
Alphatec Holdings, Inc. (NASDAQ:ATEC) Receives Average Recommendation of "Moderate Buy" from Brokerages
Alphatec Holdings, Inc. (NASDAQ:ATEC) has received a "Moderate Buy" consensus rating from twelve brokerages, with an average 12-month price target of $22.82, significantly above its recent opening price of $12.15. The company recently surpassed quarterly earnings estimates with an EPS of $0.06 against an expected $0.04 and revenue of $212.93 million, marking a 20.4% year-over-year increase. Despite strong institutional ownership (66.35%), company insiders have been net sellers, divesting approximately $11.29 million worth of stock in the last three months.
Tudor Investment Corp ET AL Has $13.09 Million Stock Position in Alphatec Holdings, Inc. $ATEC
Tudor Investment Corp ET AL significantly increased its stake in Alphatec Holdings, Inc. ($ATEC) by 608.4% to 900,491 shares, valued at approximately $13.09 million, as of Q3. Several other hedge funds also boosted their positions, indicating growing institutional interest, with institutional investors now owning 66.35% of the company. However, company insiders have been net sellers, disposing of over $11 million worth of shares in the past 90 days, though they still retain a 20.90% ownership.
Alphatec (NASDAQ:ATEC) Stock Rating Upgraded by Wells Fargo & Company
Wells Fargo & Company has upgraded Alphatec (NASDAQ:ATEC) to a "strong-buy" rating, contributing to an overall "Moderate Buy" consensus and a price target of $22.82. Despite beating quarterly EPS and revenue estimates, analysts still project a full-year loss of -$1.08 per share. Insider transactions show recent net selling, including significant sales by the CEO and EVP, though insiders still hold a substantial portion of the company's stock.
Alphatec Holdings (NasdaqGS:ATEC) Stock Price
This article provides an overview of Alphatec Holdings (NasdaqGS:ATEC) stock performance, analyst targets, and key financial details. It highlights three narratives from different analysts regarding the company's future performance, focusing on expansion drivers, improved margins, and potential limitations from cost containment and regulation, along with recent insider transactions. The company designs, develops, and advances technologies for spinal disorder treatment.
Insider Selling: Alphatec (NASDAQ:ATEC) COO Sells 260,535 Shares of Stock
Alphatec (NASDAQ:ATEC) COO Scott Lish sold 260,535 shares of the company's stock for approximately $3.20 million, reducing his holding by 24.21%. This transaction occurred on March 13th at an average price of $12.30 per share. Despite the insider selling, Alphatec exceeded quarterly EPS estimates and analysts maintain a "Moderate Buy" consensus with a price target of $22.82.
Alphatec Holdings Executives Sell Shares Under Trading Plans
Alphatec Holdings CFO John Todd Koning and COO Lish Scott both sold significant amounts of common stock on March 13, 2026, under Rule 10b5-1 trading plans. Koning sold 79,789 shares for $986,192, while Scott sold 260,535 shares for $3,204,580. Following these transactions, both executives retain substantial ownership in the company.
Alphatec (NASDAQ: ATEC) CFO sells 79,789 shares in 10b5-1 plan
Alphatec Holdings, Inc. (NASDAQ: ATEC) CFO John Todd Koning reported selling 79,789 shares of common stock on March 13, 2026, at a weighted average price of $12.36 per share. This sale, executed under a Rule 10b5-1 trading plan adopted on December 12, 2025, was primarily to cover tax withholding obligations from vesting restricted stock units. Following the transaction, Koning directly holds 600,721 shares of Alphatec.
Alphatec (ATEC) COO Scott Lish sells 260,535 shares in open-market trade
Alphatec Holdings, Inc. COO Scott Lish has sold 260,535 shares of common stock in an open-market transaction on March 13, 2026. The shares were sold at a weighted average price of $12.30, with individual trades ranging from $12.20 to $12.42. Following this sale, Lish directly holds 815,704 shares of Alphatec common stock.
ATEC6342884 Bond Price and Chart — FINRA:ATEC6342884
This article provides details on the ATEC6342884 bond issued by Alphatec Holdings, Inc. The bond has a 0.75% fixed coupon, a maturity date of March 15, 2030, and an outstanding amount of $405 million USD. Key information includes its sector (Health Technology), industry (Medical Specialties), and ISIN.
Assessing Alphatec Holdings (ATEC) Valuation After Recent Share Price Weakness
Alphatec Holdings (ATEC) has experienced significant share price weakness recently, with a 38% drop over the past three months, despite a 32.19% return over the last year. Despite this, a valuation narrative from Simply Wall St suggests the company is 50.1% undervalued, with a fair value of $24.62 per share compared to its last closing price of $12.28. This optimistic view is based on the company's operational discipline, rising margins, and future earnings potential, but acknowledges risks from shifts in spine procedures or competitor pricing pressure.
Braidwell LP Lowers Stake in Alphatec Holdings, Inc. $ATEC
Braidwell LP significantly reduced its stake in Alphatec Holdings, Inc. (NASDAQ:ATEC) by 84% in the third quarter, selling over 7.9 million shares but still retaining roughly 1.02% of the company. This institutional selling coincides with notable insider selling from Alphatec's CEO and EVP, though insiders collectively still hold 20.9% of the stock. Despite this, Alphatec exceeded quarterly earnings and revenue estimates and holds an average analyst rating of "Moderate Buy" with a target price considerably above its current trading price.
Assessing Alphatec Holdings (ATEC) Valuation After Recent Share Price Weakness
Alphatec Holdings (ATEC) has experienced significant share price weakness recently, falling 8% over the past month and 38% in the last three months, despite a 32.19% one-year total shareholder return. Simply Wall St's analysis suggests the stock is 50.1% undervalued, with a fair value estimate of $24.62 per share against its current price of $12.28, driven by expected operational improvements and revenue growth. However, this valuation could be challenged by shifts in spine procedures or competitive pressures.
Alphatec Holdings EVP of Sales Sells Over $2 Million in Company Stock
David Sponsel, EVP of Sales at Alphatec Holdings (ATEC), sold 163,452 shares of company stock for over $2 million on March 11, 2026. The sale, executed under a Rule 10b5-1 trading plan to cover tax obligations, was priced at a weighted average of $12.52 per share. Following this transaction, Sponsel retains direct ownership of 504,932 shares.
ATEC (NASDAQ: ATEC) broker files Form 144 to sell 79,789 RSUs
A Form 144 was filed by a representative for Alphatec Holdings, Inc. (NASDAQ: ATEC) proposing the sale of 79,789 restricted and performance stock units (RSUs/PSUs). The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services as the broker, with a proposed aggregate market value of $997,362.50. This notice signifies an intent to sell these equity awards, which were issuer-originated, rather than a new issuance by the company.
Scott Lish notifies sale of 19,900 ATEC shares (NASDAQ: ATEC)
Scott Lish has filed a Form 144 notice indicating a proposed sale of 19,900 shares of Alphatec Holdings, Inc. (NASDAQ: ATEC), with an intended sale date of December 16, 2025, and estimated aggregate proceeds of $389,964.35. The filing also details various issuer-issued performance stock units and restricted stock vesting entries acquired by Lish between 2023 and 2026. A Form 144 notice indicates a proposed sale and does not confirm the transaction's settlement or execution.
(ATEC) and the Role of Price-Sensitive Allocations
This article provides an AI-generated analysis for Alphatec Holdings Inc. (NASDAQ: ATEC) as of March 13, 2026. It highlights divergent sentiment, elevated downside risk due to a lack of long-term support signals, and presents three distinct trading strategies (Position, Momentum Breakout, and Risk Hedging) with specific entry, target, and stop-loss levels. The analysis also includes multi-timeframe signal analysis, showing varying support and resistance levels for near-term, mid-term, and long-term horizons, and emphasizes the role of price-sensitive allocations.
Alphatec (ATEC) EVP sells 116K shares under 10b5-1 tax plan
Alphatec Holdings, Inc.'s EVP, Craig E. Hunsaker, reported selling 116,367 shares of common stock at weighted average prices of $12.22 and $12.45 per share. These sales were conducted under a Rule 10b5-1 trading plan designed to cover tax withholding obligations from vesting restricted stock units. Additionally, Hunsaker made a gift of 600 shares, and after these transactions, he still directly holds 1,725,609 shares, indicating the sales were primarily for tax and planning purposes.
Craig Hunsaker Sells 82,765 Shares of Alphatec (NASDAQ:ATEC) Stock
Alphatec EVP Craig Hunsaker recently sold 82,765 shares of the company's stock for over $1 million, reducing his ownership by 4.58%. Despite this insider sale, Alphatec (NASDAQ:ATEC) reported strong Q4 2025 earnings, beating analyst expectations with $0.06 EPS and a 20.4% year-over-year revenue increase. The company maintains a "Moderate Buy" consensus rating from analysts, with an average price target of $22.82.
Alphatec (NASDAQ:ATEC) EVP Craig Hunsaker Sells 33,602 Shares
Alphatec EVP Craig Hunsaker sold 33,602 shares of Alphatec (NASDAQ:ATEC) stock on March 6th for over $410,000, reducing his ownership by 1.82%. This sale occurred shortly after Alphatec reported strong quarterly earnings, beating EPS and revenue expectations. Despite the insider sale, the company maintains a "Moderate Buy" rating from analysts with an average price target of $22.82.
Will Narrowing Losses and Steady 2026 Outlook Change Alphatec Holdings' (ATEC) Narrative?
Alphatec Holdings (ATEC) reported narrowing net losses in Q4 and full-year 2025 and reaffirmed its 2026 revenue outlook of approximately US$890 million. This indicates management's confidence in the company's operational progress despite the retirement of a board member. The growth-focused investment narrative for Alphatec hinges on its ability to convert increasing revenue into sustainable profits.
Vanguard Group Inc. Increases Stock Position in Alphatec Holdings, Inc. $ATEC
Vanguard Group Inc. increased its stake in Alphatec Holdings, Inc. by 2.4% during the third quarter, bringing its total ownership to 4.59% valued at $99.1 million. This increase comes despite significant insider selling activity, with company insiders offloading 1.3 million shares worth about $27.17 million in the last quarter. Alphatec also reported an earnings beat, exceeding EPS expectations and showing a 20.4% year-over-year revenue growth, leading analysts to rate the stock as a "Moderate Buy" with an average price target of $22.82.
American Century Companies Inc. Boosts Stock Position in Alphatec Holdings, Inc. $ATEC
American Century Companies Inc. increased its stake in Alphatec Holdings, Inc. (NASDAQ:ATEC) by 2.6% in the third quarter, bringing their total ownership to approximately 4.27% valued at $92.13 million. Several other institutional investors also significantly increased their positions in Alphatec, with hedge funds and institutional investors now owning 66.35% of the medical technology company's stock. Alphatec reported strong Q3 earnings, beating analyst estimates with $0.06 EPS and a 20.4% year-over-year revenue increase, while analysts maintain a "Moderate Buy" rating with an average target price of $22.82.
Quantbot Technologies LP Increases Position in Alphatec Holdings, Inc. $ATEC
Quantbot Technologies LP significantly increased its stake in Alphatec Holdings, Inc. (NASDAQ:ATEC) by 745.8% in the third quarter, now owning 184,041 shares valued at $2,676,000. Other hedge funds also adjusted their positions in the medical technology company. Alphatec has shown strong revenue growth and is generally rated as a "Moderate Buy" by analysts, despite recent insider stock sales.
Royce & Associates LP Trims Stock Position in Alphatec Holdings, Inc. $ATEC
Royce & Associates LP reduced its stake in Alphatec Holdings, Inc. by 13.4% in the third quarter, selling over 85,000 shares. Despite this, Alphatec exceeded quarterly revenue and EPS expectations, with its revenue increasing by 20.4% year-over-year. While insiders have been significant sellers of the stock, analysts largely maintain a "Moderate Buy" rating with a consensus target price higher than its current trading price.
Alphatec Holdings director Ward W. Woods retires; board reduced to seven members
Ward W. Woods has retired from Alphatec Holdings' board of directors, effective February 27, 2026, due to personal reasons. Following his departure, the board reduced its size from eight to seven members. In other news, Alphatec Holdings exceeded fourth-quarter analyst expectations with strong revenue and adjusted EPS, though its full-year 2026 revenue guidance fell short of Wall Street estimates.
Director Ward W. Woods retires from Alphatec (NASDAQ: ATEC) Board with RSU vesting
Alphatec Holdings, Inc. announced that Director Ward W. Woods has retired from its Board of Directors, effective February 27, 2026, for personal reasons. His departure is amicable, with no disagreements cited regarding company operations. In connection with his retirement, Mr. Woods' previously unvested restricted stock units from June 11, 2025, will fully vest.
Envestnet Asset Management Inc. Decreases Stake in Alphatec Holdings, Inc. $ATEC
Envestnet Asset Management Inc. significantly reduced its stake in Alphatec Holdings, Inc. by 67.7% in the third quarter, selling over 255,000 shares. Despite this institutional selling and recent insider sales totaling $29.39 million, analysts remain largely bullish on Alphatec with a "Moderate Buy" rating and an average target price of $22.82. The company recently surpassed quarterly EPS estimates and reported a 20.4% year-over-year revenue increase.
Is Narrowing Losses And Reaffirmed 2026 Outlook Altering The Investment Case For Alphatec (ATEC)?
Alphatec Holdings (ATEC) reported narrower net losses for Q4 2025 and the full year, while reaffirming its 2026 revenue outlook of approximately US$890 million. The company's management highlighted strong surgeon adoption and double-digit growth, aiming for US$20 million in free cash flow in 2026. While the reaffirmed guidance supports growth expectations, investors should be aware of the risk that continued operating losses and heavy investment could strain the balance sheet if growth decelerates.
[Form 4] Alphatec Holdings, Inc. Insider Trading Activity
Alphatec Holdings, Inc. (ATEC) EVP of Sales, David Sponsel, reported several equity award acquisitions in a recent Form 4 filing. These awards include restricted stock units (RSUs) tied to past performance, new RSU grants vesting over several years, and performance-based RSUs linked to the company's stock price reaching specific targets or achieving operational metrics. The details of these transactions were filed on February 27, 2026.
[Form 4] Alphatec Holdings, Inc. Insider Trading Activity
This article details the insider trading activity of Marshall Tyson Eliot, General Counsel and Corporate Secretary of Alphatec Holdings, Inc. The Form 4 filing indicates that Eliot received several equity awards on February 25, 2026, including restricted stock units (RSUs) tied to performance and as part of his compensation. These awards increased his directly held common shares to 648,294 and include performance-based RSUs with vesting conditions related to stock price achievements and operational metrics.
What Does the Street Think About Alphatec Holdings (ATEC)?
Alphatec Holdings (ATEC) is considered a small-cap stock with significant growth potential, as indicated by recent analyst ratings. TD Cowen maintained a Buy rating while cutting its price target to $20, citing unappreciated growth vectors. Lake Street also reiterated a Buy rating with a $25 price target. The company reported strong preliminary Q4 and full-year 2025 financial results, with total revenue rising 25% and reaffirming its adjusted EBITDA guidance, and provided a positive 2026 revenue outlook of $890 million.
What Does the Street Think About Alphatec Holdings (ATEC)?
Alphatec Holdings, Inc. (NASDAQ:ATEC) is gaining attention as a small-cap stock with significant growth potential, despite a recent price target cut by TD Cowen to $20. Lake Street maintained a Buy rating with a $25 price target. The company reported strong preliminary financial results for fiscal year 2025, with total revenue rising 25% and reaffirmed its adjusted EBITDA guidance of $91 million, along with a positive financial outlook for 2026 expecting $890 million in total revenue.
Alphatec Holdings, Inc. (NASDAQ:ATEC) Q4 2025 earnings call transcript
This article is an earnings call transcript for Alphatec Holdings, Inc. (NASDAQ:ATEC) for their Q4 2025 financial results. It presumably contains detailed discussions about the company's performance, financial figures, and outlook. Without the full content, specific details cannot be provided.
Alphatec Holdings, Inc. (NASDAQ:ATEC) Q4 2025 Earnings Call Transcript
Alphatec Holdings, Inc. (NASDAQ:ATEC) discussed its Q4 and full-year 2025 financial results, highlighting strong revenue growth of 20% in Q4 and 25% for the full year, reaching $764 million. Despite missing EPS expectations, the company emphasized its spine-focused strategy, procedural advancements like EOS Insight and Valence, and a promising partnership with Theradaptive for a next-generation BMP. Alphatec also provided an optimistic 2026 outlook, projecting continued revenue growth, increased adjusted EBITDA, and positive free cash flow.
Alphatec Holdings Reports Strong Q4 2025 Earnings with 20% Revenue Growth
Alphatec Holdings reported strong Q4 2025 results with a 20% year-over-year revenue increase to $213 million and a 61% rise in adjusted EBITDA to $33 million, driven by robust performance in the spine surgery sector. The company also launched new products, including 3D-printed implants, and provided an optimistic 2026 outlook, forecasting 17% revenue growth and an adjusted EBITDA target of $134 million, indicating sustained financial health and market position. Analyst ratings are generally positive, with some price target adjustments reflecting confidence in future growth.
Alphatec: Fourth Quarter Financial Results Overview
Alphatec Holdings Inc. reported a Q4 net loss of $21.7 million, or $0.14 per share, but adjusted earnings of $0.06 per share surpassed analyst expectations of $0.04. The medical device company generated $212.9 million in revenue for the quarter and $764.2 million for the full year. Despite a 34% decline in stock price year-to-date, shares have increased by 29% over the past twelve months.
Earnings Flash (ATEC) Alphatec Holdings, Inc. Posts Q4 Adjusted EPS $0.06 per Share, vs. FactSet Est of $0.04
Alphatec Holdings, Inc. (ATEC) announced adjusted EPS of $0.06 per share for Q4, exceeding the FactSet estimate of $0.04. The article also provides recent news regarding insider stock sales and analyst rating updates for the company. Alphatec Holdings, a medical device company focused on surgical treatment for spine disorders, has an average target price of $24.62 from analysts.
Alphatec Holdings Earnings Review: Q4 Summary - Alphatec Holdings (NASDAQ:ATEC)
Alphatec Holdings (NASDAQ:ATEC) reported its Q4 earnings, beating estimated EPS by 400.0%. The company posted an EPS of $0.06 against an estimate of $-0.02, with revenue up by $36.13 million year-over-year. This positive performance follows a similar beat in the previous quarter, which led to a share price increase.
